Treatment strategies for ER/PR positive and HER2-positive breast cancer include hormone targeted therapies like tamoxifen (4, 5), aromatase inhibitors (6) and HER-2 specific monoclonal antibody, trastuzumab (7) which are often used in combination with chemotherapeutic agents like paclitaxel (8). The gene discussed is ERBB2; the disease is breast cancer.